Lembaga Tabung Haji has become a substantial shareholder in Duopharma Biotech Bhd following its latest acquisition of shares in the pharmaceutical company.

According to a filing with Bursa Malaysia on Tuesday, the pilgrimage fund crossed the 5% disclosure threshold after purchasing 500,000 shares, representing a 0.052% stake, on Monday. The acquisition raised Tabung Haji’s total shareholding in Duopharma to 5.046%, equivalent to approximately 48.54 million shares.

Lembaga Tabung Haji has emerged as a substantial shareholder of Duopharma Biotech Bhd after acquiring 500,000 shares on Monday, bringing its total stake to 5.046%, representing 48.54 million shares.

With this development, Tabung Haji joins the list of key institutional shareholders in Duopharma. Permodalan Nasional Bhd (PNB) remains the company’s largest shareholder with a 44.104% stake, while the Employees Provident Fund (EPF) holds 9.087%.

For more details, visit the full article here.